Biopsychosocial Response to the COVID-19 Lockdown in People with Major Depressive Disorder and Multiple Sclerosis

被引:6
|
作者
Siddi, Sara [1 ,2 ]
Gine-Vazquez, Iago [1 ,2 ]
Bailon, Raquel [3 ,4 ]
Matcham, Faith [5 ,6 ]
Lamers, Femke [7 ,8 ]
Kontaxis, Spyridon [3 ,4 ]
Laporta, Estela [4 ]
Garcia, Esther [4 ,9 ]
Arranz, Belen [1 ,2 ]
Dalla Costa, Gloria [10 ]
Guerrero, Ana Isabel [11 ]
Zabalza, Ana [11 ]
Buron, Mathias Due [12 ]
Comi, Giancarlo [10 ,13 ]
Leocani, Letizia [10 ,14 ]
Annas, Peter [15 ]
Hotopf, Matthew [5 ]
Penninx, Brenda W. J. H. [7 ,8 ]
Magyari, Melinda [12 ]
Sorensen, Per S.
Montalban, Xavier [11 ]
Lavelle, Grace [5 ]
Ivan, Alina [5 ]
Oetzmann, Carolin [5 ]
White, Katie M. [5 ]
Difrancesco, Sonia [7 ]
Locatelli, Patrick [16 ]
Mohr, David C. [17 ]
Aguilo, Jordi [4 ,9 ]
Narayan, Vaibhav [18 ]
Folarin, Amos [5 ]
Dobson, Richard J. B. [5 ]
Dineley, Judith [5 ]
Leightley, Daniel [5 ]
Cummins, Nicholas [5 ]
Vairavan, Srinivasan [18 ]
Ranjan, Yathart [5 ]
Rashid, Zulqarnain [5 ]
Rintala, Aki [19 ,20 ]
De Girolamo, Giovanni [21 ]
Preti, Antonio [22 ]
Simblett, Sara [5 ]
Wykes, Til [5 ]
Myin-Germeys, Inez [19 ]
Haro, Josep Maria [1 ,2 ]
机构
[1] Parc Sanitari St Joan de Deu, Fundacio St Joan de Deu, CIBERSAM, Madrid 28029, Spain
[2] Univ Barcelona, Barcelona 08007, Spain
[3] Univ Zaragoza, Aragon Inst Engn Res I3A, Zaragoza 50001, Spain
[4] Ctr Invest Biomed Red Area Bioingn Biomat & Nanom, Madrid 28029, Spain
[5] Kings Coll London, Inst Psychiat, Psychol & Neurosci, London SE5 8AF, England
[6] Univ Sussex, Sch Psychol, Falmer BN1 9QH, England
[7] Vrije Univ, Dept Psychiat, Amsterdam UMC, NL-1081 HV Amsterdam, Netherlands
[8] Amsterdam Publ Hlth Res Inst, Mental Hlth Program, NL-1081 BT Amsterdam, Netherlands
[9] Univ Autonoma Barcelona, Microelect & Sistemas Elect, Bellaterra 08193, Spain
[10] Univ Vita Salute San Raffaele, Fac Med, I-20132 Milan, Italy
[11] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Inst Recerca,Dept Neurol Neuroimmuno, Multiple Sclerosis Ctr Catalonia Cemcat, Barcelona 08035, Spain
[12] Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, Dept Neurol, Rigshosp, DK-2100 Copenhagen, Denmark
[13] Casa Cura Policlin, I-20144 Milan, Italy
[14] Sci Inst San Raffaele, Inst Expt Neurol, Expt Neurophysiol Unit, INSPE, I-20132 Milan, Italy
[15] H Lundbeck & Co AS, DK-2500 Valby, Denmark
[16] Univ Bergamo, Dept Engn & Appl Sci, I-24129 Bergamo, Italy
[17] Northwestern Univ, Ctr Behav Intervent Technol, Dept Preventat Med, Chicago, IL 60611 USA
[18] Janssen Res & Dev LLC, Res & Dev Informat Technol, Titusville, NJ 08560 USA
[19] Katholieke Univ Leuven, Ctr Contextual Psychiat, Dept Neurosci, B-7001 Leuven, Belgium
[20] LAB Univ Appl Sci, Fac Social Serv & Hlth Care, Lahti 15210, Finland
[21] IRCCS Inst Ctr San Giovanni Dio Fatebenefratelli, I-25125 Brescia, Italy
[22] Univ Torino, Dipartimento Neurosci, I-10126 Turin, Italy
关键词
COVID-19; SARS-CoV-2; major depressive disorder; multiple sclerosis; depression severity; heart rate; stress; social activity; physical activity; decentralized; HEART-RATE-VARIABILITY; STRESSFUL LIFE EVENTS; MENTAL-HEALTH; SEDENTARY BEHAVIOR; IMPACT; METAANALYSIS; ASSOCIATION; VALIDITY; ANXIETY; RISK;
D O I
10.3390/jcm11237163
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Changes in lifestyle, finances and work status during COVID-19 lockdowns may have led to biopsychosocial changes in people with pre-existing vulnerabilities such as Major Depressive Disorders (MDDs) and Multiple Sclerosis (MS). Methods: Data were collected as a part of the RADAR-CNS (Remote Assessment of Disease and Relapse-Central Nervous System) program. We analyzed the following data from long-term participants in a decentralized multinational study: symptoms of depression, heart rate (HR) during the day and night; social activity; sedentary state, steps and physical activity of varying intensity. Linear mixed-effects regression analyses with repeated measures were fitted to assess the changes among three time periods (pre, during and post-lockdown) across the groups, adjusting for depression severity before the pandemic and gender. Results: Participants with MDDs (N = 255) and MS (N = 214) were included in the analyses. Overall, depressive symptoms remained stable across the three periods in both groups. A lower mean HR and HR variation were observed between pre and during lockdown during the day for MDDs and during the night for MS. HR variation during rest periods also decreased between pre- and post-lockdown in both clinical conditions. We observed a reduction in physical activity for MDDs and MS upon the introduction of lockdowns. The group with MDDs exhibited a net increase in social interaction via social network apps over the three periods. Conclusions: Behavioral responses to the lockdown measured by social activity, physical activity and HR may reflect changes in stress in people with MDDs and MS. Remote technology monitoring might promptly activate an early warning of physical and social alterations in these stressful situations. Future studies must explore how stress does or does not impact depression severity.
引用
收藏
页数:20
相关论文
共 50 条
  • [1] COVID-19 Vaccine Response in People with Multiple Sclerosis
    Tallantyre, Emma C.
    Vickaryous, Nicola
    Anderson, Valerie
    Asardag, Aliye Nazli
    Baker, David
    Bestwick, Jonathan
    Bramhall, Kath
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Godkin, Andrew
    Grant, Leanne
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jones, Meleri
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Robertson, Neil P.
    Schmierer, Klaus
    Scurr, Martin J.
    Shah, Sita Navin
    Simmons, Jessica
    Upcott, Matthew
    Willis, Mark
    Jolles, Stephen
    Dobson, Ruth
    ANNALS OF NEUROLOGY, 2022, 91 (01) : 89 - 100
  • [2] Impact of the COVID-19 lockdown in Multiple Sclerosis patients
    Mrabet, S.
    Souissi, A.
    Hmissi, L.
    Mekni, H.
    Ben Djebara, M.
    Kacem, I.
    Gouider, R.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 688 - 688
  • [3] COVID-19 vaccination and humoral immune response in people with multiple sclerosis
    Oreja-Guevara, C.
    Ramirez, C. I.
    Alba-Suarez, E.
    Gomez-Estevez, I.
    Bullon-Sanchez, C.
    Castro-Hernandez, M.
    Martinez-Perez, E.
    Diaz-Diaz, J.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 728 - 728
  • [4] Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
    Tallantyre, Emma C.
    Scurr, Martin J.
    Vickaryous, Nicola
    Richards, Aidan
    Anderson, Valerie
    Baker, David
    Chance, Randy
    Evangelou, Nikos
    George, Katila
    Giovannoni, Gavin
    Harding, Katharine E.
    Hibbert, Aimee
    Ingram, Gillian
    Jolles, Stephen
    Jones, Meleri
    Kang, Angray S.
    Loveless, Samantha
    Moat, Stuart J.
    Robertson, Neil P.
    Rios, Francesca
    Schmierer, Klaus
    Willis, Mark
    Godkin, Andrew
    Dobson, Ruth
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 64
  • [5] Impact of COVID-19 lockdown on progressive multiple sclerosis patients
    Vercellino, Marco
    Bosa, Chiara
    Alteno, Anastasia
    Schillaci, Valentina
    Petracca, Manuel
    Marasciulo, Stella
    Cavalla, Paola
    NEUROLOGICAL SCIENCES, 2022, 43 (05) : 2943 - 2946
  • [6] Impact of COVID-19 lockdown on progressive multiple sclerosis patients
    Marco Vercellino
    Chiara Bosa
    Anastasia Alteno
    Valentina Schillaci
    Manuel Petracca
    Stella Marasciulo
    Paola Cavalla
    Neurological Sciences, 2022, 43 : 2943 - 2946
  • [7] Causal associations between major depressive disorder and COVID-19
    Baranova, Ancha
    Zhao, Yi
    Cao, Hongbao
    Zhang, Fuquan
    GENERAL PSYCHIATRY, 2023, 36 (02)
  • [8] Response of the multiple sclerosis community to COVID-19
    Ciccarelli, Olga
    Cohen, Jeffrey A.
    Thompson, Alan
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (10) : 1134 - 1136
  • [9] COVID-19 in people with multiple sclerosis treated with ocrelizumab
    Hauser, S. L.
    Gold, R.
    Cutter, G.
    Fitovski, K.
    Schneble, H. -M.
    Whitley, L.
    Jessop, N.
    Sauter, A.
    Wang, Q.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 762 - 762
  • [10] COVID-19 and multiple sclerosis: a thematic analysis of the unique experiences of people with multiple sclerosis during the COVID-19 pandemic
    Simcock-Davies, A.
    Da Silva, A.
    Craig, E. M.
    Middleton, R. M.
    Nicholas, R.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 686 - 687